Jasper Therapeutics holds special shareholder meeting

• Jasper Therapeutics held a special shareholder meeting on September 30, 2026.
• Shareholders backed a charter amendment authorizing the board to implement a reverse stock split by Dec. 31, 2026.
• The split ratio was authorized within a 1-for-15 to 1-for-35 range; execution remains at the board’s discretion.
• Investors also adopted an amendment to raise authorized common shares to 675,000,000 from 490,000,000, subject to board action.
• A measure to allow adjournment to solicit additional proxies, if needed, was also adopted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106651), on October 05, 2026, and is solely responsible for the information contained therein.